Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Бібліографічні деталі
Автори:	Serres, F, Millan, M, Sharp, T
Формат:	Journal article
Мова:	English
Опубліковано:	2012

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
за авторством: Junko Takata, та інші
Опубліковано: (2019-08-01)

Differences between SSRI and SNRI in depression treatment
за авторством: Mateusz Grego, та інші
Опубліковано: (2025-01-01)

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
за авторством: Helga Zoega, та інші
Опубліковано: (2015-01-01)

Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
за авторством: Patrick Pasi, та інші
Опубліковано: (2023-04-01)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
за авторством: Philippe Courtet
Опубліковано: (2010-08-01)

Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
за авторством: Helen Koechlin, та інші
Опубліковано: (2021-12-01)

Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis
за авторством: Rabail Altaf, та інші
Опубліковано: (2021-09-01)

Age-Dependent Analysis of Suicidal Ideation, Suicide Attempts, and Suicides Associated with SSRI and SNRI Drugs Based on Pharmacovigilance Data
за авторством: Daria Schetz, та інші
Опубліковано: (2024-12-01)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
за авторством: Rosenberg T, та інші
Опубліковано: (2017-11-01)

Comparação entre SNRI e SSRI na indução da remissão da perturbação depressiva major: uma revisão baseada na evidência
за авторством: Ana Dias Amaral
Опубліковано: (2014-05-01)

In-Utero SSRI and SNRI Exposure and the Risk of Neurodevelopmental Disorders in Children: A Population-Based Retrospective Cohort Study Utilizing Linked Administrative Data
за авторством: Deepa Singal, та інші
Опубліковано: (2018-09-01)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
за авторством: Richard G. W. Proudman, та інші
Опубліковано: (2020-08-01)

Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.
за авторством: Franklin, M, та інші
Опубліковано: (1998)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
за авторством: Richard G.W. Proudman, та інші
Опубліковано: (2022-04-01)

Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study
за авторством: Christensen MC, та інші
Опубліковано: (2024-07-01)

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
за авторством: Griffiths, R, та інші
Опубліковано: (1999)

In-Utero SSRI and SNRI Exposure and the Risk of Long Term Adverse Mental and Educational Outcomes in Children: A Population-Based Retrospective Cohort Study Utilizing Linked Administrative Data
за авторством: Deepa Singal, та інші
Опубліковано: (2018-09-01)

Serotonin and noradrenaline reuptake inhibitors improve micturition control in mice.
за авторством: Marco Redaelli, та інші
Опубліковано: (2015-01-01)

Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter
за авторством: Huahua Zhang, та інші
Опубліковано: (2023-05-01)

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
за авторством: Dekeyne, A, та інші
Опубліковано: (2012)

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
за авторством: Kevin P. Kennedy
Опубліковано: (2022-10-01)

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
за авторством: Andreas Austgulen Westin, та інші
Опубліковано: (2017-01-01)

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine.
за авторством: Hajós-Korcsok, E, та інші
Опубліковано: (2000)

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
за авторством: Jonathan Henssler, та інші
Опубліковано: (2023-05-01)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
за авторством: Andreas Austgulen Westin, та інші
Опубліковано: (2018-01-01)

β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain
за авторством: Ipek Yalcin, та інші
Опубліковано: (2009-03-01)

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
за авторством: Dekeyne, A, та інші
Опубліковано: (2008)

A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
за авторством: Christopher Robinson, та інші
Опубліковано: (2022-05-01)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
за авторством: Pei, Q, та інші
Опубліковано: (2004)

Noradrenaline increases intracellular Ca2+ concentration in epithelial cells via α2-adrenoceptors in isolated mouse ileal crypts
за авторством: Tomoko Kimyo, та інші
Опубліковано: (2022-03-01)

Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors
за авторством: Francisca eMeyer, та інші
Опубліковано: (2014-08-01)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
за авторством: Karolina Pytka, та інші
Опубліковано: (2015-01-01)

Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.
за авторством: Kohji Takara, та інші
Опубліковано: (2012-01-01)

An fMRI study on the effects of the dopamine & noradrenaline reuptake inhibitor bupropion on reward processing in depressed individuals
за авторством: Pickenhan, L
Опубліковано: (2021)

Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
за авторством: Somayeh Tajik, та інші
Опубліковано: (2020-06-01)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
за авторством: Sandra Cuenca Carcelén, та інші
Опубліковано: (2021-01-01)

Characterization of Noradrenaline-Induced Increases in Intracellular Ca2+ Levels in Chinese Hamster Ovary Cells Stably Expressing Human α1A-Adrenoceptor
за авторством: Takahiro Horinouchi, та інші
Опубліковано: (2007-01-01)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
за авторством: Zhong Z, та інші
Опубліковано: (2017-11-01)

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Схожі ресурси

Схожі ресурси